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Disclosing virulence factors from pathogens is required to better understand the
pathogenic mechanisms involved in their interaction with the host. In the case of
Trypanosoma cruzi several molecules are associated with virulence. Among them,
the trans-sialidase (TS) has arisen as one of particular relevance due to its effect on
the immune system and involvement in the interaction/invasion of the host cells. The
presence of conserved genes encoding for an inactive TS (iTS) isoform is puzzlingly
restricted to the genome of parasites from the Discrete Typing Units TcII, TcV, and
TcVI, which include highly virulent strains. Previous in vitro results using recombinant
iTS support that this isoform could play a different or complementary pathogenic role
to that of the enzymatically active protein. However, direct evidence involving iTS in
in vivo pathogenesis and invasion is still lacking. Here we faced this challenge by
transfecting iTS-null parasites with a recombinant gene that allowed us to follow its
expression and association with pathological events. We found that iTS expression
improves parasite invasion of host cells and increases their in vivo virulence for mice
as shown by histopathologic findings in heart and skeletal muscle.
Keywords: Discrete Typing Units, inactive trans-sialidase, pathogenesis, Trypanosoma cruzi virulence, virulence
factors
INTRODUCTION
Chagas disease, the American trypanosomiasis, is a chronic, disabling parasitic disease caused by
the flagellate protozoon Trypanosoma cruzi. Currently, about 6 million people are infected and
13% of Latin America population is at risk of infection, representing a major health, social, and
economic problem in Latin America and a global emerging threat due to the population migration
(Rassi et al., 2010; WHO-World Health Organization, 2015).
During the acute phase of the infection, T. cruzi induces several immune system alterations that
allow the parasite to disseminate and persist in the host (Dos Reis, 2011). Several parasite molecules
are associated with virulence. Among them the trans-sialidase (TS), an enzyme expressed and shed
by the trypomastigote stage, has arisen as one of particular relevance due to its effect on the immune
system and involvement in the interaction/invasion of the host cell, playing also a central role in the
parasite biology (Oliveira et al., 2014). T. cruzi is unable to synthesize sialic acids de novo and thus,
the surface membrane glycoconjugates are sialylated by TS that obtain this sugar from the host
glycoconjugates (Mucci et al., 2017). Acquisition of the sialyl residue allows the parasite to survive
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in blood and disseminate the infection. This virulence factor
is also shed and distributed by the bloodstream thanks to a
repetitive antigenic C-terminus extension known as SAPA (for
Shed Acute Phase Antigen) that extends its half-life in blood
(Buscaglia et al., 1999; Alvarez et al., 2004). By this way, TS
acts systemically inducing several abnormalities in the host’s
immune system including depletion of thymocytes (Leguizamón
et al., 1999; Mucci et al., 2006) and absence of germinal
centers in secondary organs (Risso et al., 2007), along with
thrombocytopenia and erythropenia (Tribulatti et al., 2005).
A large TS gene family of about 1,430 members has become
evident after the release of the T. cruzi genome (El-Sayed
et al., 2005). TS-homologous proteins are encoded by genes
originally distributed in four families (Campetella et al., 1992)
now separated in eight groups (Freitas et al., 2011). Only one
of these groups contains about a dozen genes that encodes for
the active enzyme. This figure is certainly underestimated due
to the inevitable collapse during the assembly of almost identical
sequences. In fact, the gene group that includes the enzymatically
active TS (aTS) was estimated to contain from just a couple
to about 150 genes by using different quantification techniques
along several T. cruzi strains (Cremona et al., 1999; Burgos
et al., 2013). These TS-encoding genes are in turn distributed
about in halves based in the presence of a T/C transition in
the codon that encodes the Tyr342, which is crucial in the
enzyme activity (Cremona et al., 1995). This mutation, that
leads to a Tyr342His, is notably conserved as such in all the
genes from different parasites strains that encode the so-called
enzymatically-inactive proteins (iTS) of this family. However,
iTS-encoding genes do not contain other inactivating alterations
in their sequence (cumulative mutations, insertions/deletions,
stop codons, etc.) being thus not pseudogenes abandoned along
the evolution (Cremona et al., 1995; Burgos et al., 2013).
T. cruzi population is clonal and includes six main Discrete
Typing Units (DTU) known as TcI to TcVI (Zingales et al.,
2009). These DTUs are characterized by genetic tags, being
the expression of TS a biological marker associated with their
differential virulence (Risso et al., 2004). From the TS genes
sequences available in data banks, we have designed a collection
of primers that allow the amplification and sequencing of the
region where the T/Cmutation (encoding Tyr342His) is included.
After analyzing more than 30 parasite isolates from different
hosts along the Americas (Burgos et al., 2013) we found that, in
contrast to higher-virulence strains (from DTUs TcII, TcV, and
TcVI), lower-virulence parasite strains (from DTUs TcI, TcIII,
and TcIV), which display reduced pathogenic findings in mice
with low mortality, do not have the iTS-encoding genes (Risso
et al., 2004; Burgos et al., 2013). It can be therefore postulated that
the acquisition of the iTS gene during segregation in evolution
is associated with parasite virulence (Burgos et al., 2013).
Working with a recombinant iTS, we and others (Cremona
et al., 1999; Todeschini et al., 2002a) determined an associated
lectin-like activity binding to appropriate substrate sugars on
the cell surfaces and in solution. Even more, the analysis of this
TS isoform by crystallographic studies (Oppezzo et al., 2011)
indicates that it hydrolyzes a substrate sugar, although at a much
lower rate than its aTS counterpart, which might allow the
iTS to bind and release, allowing its recycling. The presence of
conserved genes coding for the iTS was always puzzling. The
notably conservation of His342 along different parasite DTUs,
strongly supports a defined biological function that involves the
interaction with the sugar substrate. The evolutionary acquisition
by virulent parasites of iTS is a challenging hypothesis (Burgos
et al., 2013). Studies with recombinant iTS allowed to associate
this isoform with immune alterations such as costimulation
and deviation of the elicited response (Todeschini et al., 2002b;
Ruiz Díaz et al., 2015). Recently, we have reported that iTS/aTS
participate in the manipulation of the T CD4 cells all along
their maturation stages favoring the elicitation of a TH2 response
(Ruiz Díaz et al., 2015). However, the actual relevance of iTS in
the pathogenesis of Chagas disease remains elusive since direct
evidence involving iTS in in vivo pathogenesis and invasion is
still lacking.
Taken together, these findings suggest that iTS proteins could
have alternative or complementary roles to the active TS in
parasite virulence for mammals. However, due to the inherent
difficulties to distinguish the expression of two proteins that
essentially differ in a single aminoacid residue, this hypothesis has
not yet been addressed. Taking advantage of the absence of iTS
genes in the TcI low-virulence parasites (Burgos et al., 2013), here
we faced this challenge by transfecting iTS-null parasites with a
recombinant iTS gene that allowed us to follow its expression and
association with pathological events.
MATERIALS AND METHODS
Animals
This study was carried out in accordance with the
recommendation of the Committee on the Ethics of Animal
Experiments of the Universidad Nacional de San Martín
(UNSAM), following the recommendations of the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health. The protocol was approved by the Institutional
Committee on the Ethics of Animal Experiments of the UNSAM
(CICUAE). C3H/HeJ and BALB/cJ mice were obtained from
The Jackson Labs and CF1 from Charles River and bred in
our facilities. Male mice (60–90 days old) were used in all
experiments. Sprague Dawley suckling rats were obtained from
the Animal Facility of the Facultad de Veterinaria, Universidad
de Buenos Aires.
Parasite Culture
Epimastigote forms of the K98 clone, derived from T. cruzi CA-I
strain (Gonzalez Cappa et al., 1999), DTU TcI lacking of iTS
gene (Burgos et al., 2013), were grown at 28◦C in liver infusion
tryptose (LIT) medium supplemented with 10% fetal bovine
serum (FBS) as described by Camargo (1964). Mammalian stages
were grown in Vero cell cultures by infecting cells withmetacyclic
trypomastigote derived from epimastigote cultures (Zingales and
Colli, 1985).
DNA and Plasmid Constructions
Recombinant genes encoding for iTS and aTS, including
twenty-four SAPA repeats and a 3XFLAG epitope together with
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the 5′UTR and 3′UTR were engineered from previously reported
genes sequences (Cremona et al., 1995; Jäger et al., 2008). Regions
of interest were amplified by PCR and synthetic DNA encoding
the 3XFLAG epitope was inserted and assembled in pGEMT-
Easy (see scheme in Figure 1A). The full constructs were cloned
into the EcoRV-SalI sites of the T. cruzi expression vector
pTrex-Omni, kindly provided by Dr. Claudio Pereira (Cámara
et al., 2013). The final constructs were fully sequenced. For
full sequences see GenBank accession numbers MF405919 and
MF405920.
Parasite Transfection
Transfections were carried out with a BTX 600 electroporator in
2-mm gap cuvettes. Epimastigotes (300 × 106) were harvested
and washed with LIT medium, resuspended in 0.4ml of LIT with
100µg supercoiled plasmid DNA. The electroporation setting
was: 1,500 µF, 335V, and 24 . Parasites were recovered in
5ml of LIT supplemented with 10% FBS and 48 h later G418
(Sigma) was added at a final concentration of 500µg/ml. The neo
resistance gene was used for selection and as an internal control
of transfection levels since it is transcribed polycistronically from
the same promoter (Di Noia, 2000).
In Vitro Parasite Differentiation and Cloning
Metacyclic trypomastigote were obtained from epimastigote
cultures by nutritional stress as described (De Lima et al., 2008).
After differentiation from epimastigotes, K98 trypomastigotes
transfected with pTrexO (vector empty, T-TO), pTrexO-
iTS (T-iTS), and pTrexO-aTS (T-aTS) were obtained.
Trypomastigotes were cloned by limiting dilution in Vero
cell cultures. Then, parasites were cloned by micromanipulation
(NT 88 V3, Nikon Narishige, Japan) under observation in an
inverted microscope (Nikon Eclipse TE-300, Nikon, Japan).
Vero cell cultures were then infected with a single parasite/well.
Protein Detection
Western blots were performed using total T. cruzi extracts
fractionated by electrophoresis in polyacrylamide denaturing gels
and transferred to polyvinylidene fluoride membranes. They
were treated for 1 h with 2.5% BSA in PBS and then incubated
with the primary antibody overnight, using rabbit IgG anti-FLAG
diluted 1:300 (Sigma). Membranes were then washed and
incubated with IRDye 800CW-labeled goat antibodies anti-rabbit
IgG (Licor Biosciences) (1/10,000). An Odyssey clx infrared
imaging system was used to analyze them.
Confocal Microscopy
Expression of iTS and aTS recombinant proteins by
trypomastigotes were analyzed by confocal microscopy.
Approximately 106 parasites were washed with PBS
supplemented with 1% BSA. Parasites were incubated with rabbit
IgG anti-FLAG (Sigma, diluted 1:300) to detect recombinant
proteins and the mouse monoclonal antibody (mAb) 13G9
anti-TS (1:100) (Buschiazzo et al., 2002), to detect all trans-
sialidases either endogenous or recombinant. Parasites were
labeled with secondary AlexaFluor568-antibodies anti-rabbit
IgG and AlexaFluor488-anti-mouse IgG (diluted 1:1,000, both
from Biolegend). Fluorescence imaging was carried out under an
Olympus FV1000 microscope equipped with a Plan APO N 60x
oil, 1.42 NA, FN 26.5 objective.
Flow Cytometry
Approximately 106 transfected trypomastigotes were washed
with PBS supplemented with 1% FBS and incubated with
rabbit antibodies anti-FLAG (Sigma) and with mAb 13G9.
Then, parasites were labeled with AlexaFluor488-antibodies
anti-rabbit IgG and Phycoerythrin (PE)-anti-mouse IgG (both
from Biolegend, at 1:500 dilution). Parasites were then fixed with
4% paraformaldehyde in PBS and fluorescence was analyzed in a
CyFlow space cytometer (Partec, Germany).
TS Activity in in Vitro Assays
Enzymatic activity was assayed in parasites and their
supernatants after allowing them to shed for 1 h at 37◦C in
PBS-BSA. The transference of the sialyl residue from 3′sialyl-
lactose to [14C]-lactose was performed as described earlier
(Leguizamón et al., 1994).
Recombinant iTS Production and
Purification
Recombinant iTS (riTS) (Cremona et al., 1995) was expressed
in Escherichia coli BL21 and purified to homogeneity by
immobilized metal affinity chromatography through Ni2+-
charged Hi-Trap chelating columns (GE Healthcare) and
ion-exchange chromatography (Mono Q; GE Healthcare) as
described previously (Leguizamón et al., 1999).
Vero Cells Infection
Approximately 104 Vero cells were plated in 24-well plates
containing round glass coverslips with DMEM (Gibco)
supplemented with 10% FBS and penicillin/streptomycin.
Vero cell infection was allowed for 1 or 18 h at 37◦C at a
multiplicity of infection (moi) of 1:1, using cell culture-derived
trypomastigotes from T. cruzi transfected clones. After infection,
cultures were washed with PBS to eliminate free parasites and
re-incubated with fresh medium for 3 days before fixation
with 4% paraformaldehyde in PBS. Fixed cultures were stained
with DAPI, and the coverslips mounted onto glass slides with
Fluorsave (Calbiochem) for microscopic analysis. The number
of infected cells and the number of amastigotes per cell were
determined by counting 500 Vero cells per coverslip for each
group. Three independent experiments were performed for each
infection.
Infection with Recombinant iTS Preincubation Assays
Vero cells were incubated with riTS (5, 15, and 50µg/ml) during
30min. Then, cells were washed twice with PBS before starting
T. cruzi infection during 1 h at 37◦C (moi 1:10), using cell
culture-derived trypomastigotes from T. cruzi transfected clones.
Three days after, fixing, staining and analysis were carried out
as described above. In other set of assays, T. cruzi infection was
carried out in riTS presence (50µg/ml) but without the washing
steps before parasite addition. Vero infection were analyzed as
above.
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FIGURE 1 | Expression of iTS and aTS recombinant proteins. (A) Schematic representation of iTS and aTS recombinant genes. The TSs with an inserted 3XFLAG
epitope-encoding sequences were cloned together with the 3′ and 5′ UTRs into the pTrex-Omni vector. The location of the T/C transition encoding for Tyr (aTS) or His
(iTS) respectively, is shown. For further details, see GenBank accession numbers MF405919 and MF405920. (B) Flow cytometry analysis of TSs parasite expression.
TS expression on T-O, T-iTS, and T-aTS parasites was followed with anti-FLAG antibody (Upper panel) and mAb 13G9 (Lower panel). Isotype control, T-O parasites,
were treated with secondary antibodies only. (C) Expression of recombinant TSs by Western blot. Anti-FLAG reactivity was only observed in T-iTS and T-aTS
trypomastigotes. (D) Surface expression pattern of TSs. Confocal images show a similar surface expression pattern of TSs (observed by mAb 13G9 in red) and
recombinant TSs (anti-FLAG in green). Fluorescence intensity profiles shows overlapping signals. (E) Ex vivo expression of trans-sialidase activity. Both supernatant
and extracts, obtained after trypomastigotes shedding, showed that T-aTS express higher activity respect to T-iTS and T-O parasites (p < 0.05). The level of TS
expression in T-iTS and T-O were similar. Results are expressed as mean ± SEM of the replicate values of three independent assays *p < 0.05.
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Primary Cardiocytes and Cardiac
Fibroblasts Isolation
Hearts were obtained from Sprague Dawley rats (3–5 days
old), and washed twice in PBS-1% glucose. Then minced and
digested in trypsin 0.16%, collagenase 0.016%, and DNase I
0.002% for 8min for 6–7 times at 37◦C with periodic mixing.
Digests were pooled, stopped with cold PBS containing glucose
1%, FBS 4%, and DNAse I 0.004%. Supernatant was then
transferred to a 15 milliliters centrifuge tube and centrifuged at
4◦C, 800 G for 10min. The pellet was collected and washed in
DMEM/F12 (Gibco) with 10% FBS and penicillin/streptomycin.
Cells were incubated at 106 cell/well in six-well plates. After 3 h,
non-adherent cells (cardiomyocytes) were removed and plated
onto 24-well plates containing glass coverslips and DMEM/F12
supplemented with 10% FBS (Gibco) and antibiotics. The
adherent cells (mainly cardiac fibroblasts) were grown in DMEM
with 10% FBS and antibiotics (Wallukat and Wollenberger,
1987). Cells were infected at a moi 1:1 cell/parasite, using 105
cells. The interaction time was 1 or 18 h.
Macrophages Infection
Macrophages were harvested from the peritoneal cavity of
C3H/HeJ and BALB/cJ naive mice. Cells were harvested with
cold RPMI 1640 (Gibco). Peritoneal macrophages were plated on
coverslips in 24-well plates (105 cells/well). After 1 h at 37◦C in
5% CO2, adherent cells were washed with PBS and cultured in
DMEM supplemented with 5% FBS plus penicillin/streptomycin.
Peritoneal macrophages were infected at a moi 1:1 cell/parasite
for 18 h following the same protocol as above.
Mice Infection
Groups of five CF1 male mice (15 days old) were inoculated
intraperitoneally with 5 × 104 Vero cell culture-derived
trypomastigotes. Then, bloodstream parasites were used to infect
twelve BALB/cJ male mice (60 days old) per group with 5
× 104 bloodstream trypomastigotes. Mice were observed daily
to determine mortality and morbidity. Circulating parasites
were monitored starting at 11 days post-infection (dpi) and
parasitaemia was evaluated using a Neubauer hemocytometer
(Risso et al., 2004).
Histopathology
Heart and skeletal muscle samples were collected from non-
infected and infected mice, fixed in 4% paraformaldehyde
and embedded in paraffin. Five-micron sections were codified,
stained with hematoxylin-eosin, and evaluated under light
microscope as described elsewhere (Postan et al., 1983; Martin
et al., 2007). Briefly, inflammation rates in cardiac samples
(auricles and ventricles) and skeletal muscle sections were graded
from 0 to 4 for normal, focal or a single inflammatory focus,
multifocal but non-confluent inflammatory infiltrates, confluent
inflammation with partial section involvement, and diffuse
inflammation extended through the section, respectively. For
each heart sample an inflammation score was taken as an average
of all analyzed regions. All slides were evaluated independently
by researchers who were blinded to the sample status.
Statistical Analysis
Data were expressed as means ± standard errors. The Student
t-test was used to analyze the statistical significance of assays. The
Log-rank (Mantel Cox) test was used to compare survival curves.
Presence of amastigotes nest among infected groups was analyzed
by Fisher exact test. Differences were considered significant at p
< 0.05. All analyses were performed with Prism software (version
5.0; GraphPad).
RESULTS
iTS Recombinant Proteins Expression in
Transfected Parasites
In order to obtain T. cruzi expressing the inactive trans-sialidase
protein (iTS) low virulence K98 parasites, naturally lacking
of iTS genes (Burgos et al., 2013), were used. Parasites were
genetically modified by transfection with a recombinant iTS
gene cloned into pTrexO expression vector (see scheme in
Figure 1A). K98 parasites transfected with the empty vector or
carrying the recombinant aTS gene (enzymatically active trans-
sialidase-encoding gen) were used as experimental controls. Both
constructs (pTrexO-aTS and pTrexO-iTS) also contain the 5′
and 3′ UTRs of the wild type TS genes (Jäger et al., 2008)
required to drive their expression into the trypomastigote stage.
Constructions also contain the sequences encoding signal that
lead proteins to the plasmatic membrane, 24 repeats of the SAPA
antigen and a 3XFLAG epitope added to distinguish recombinant
proteins from those native ones. Epimastigotes of the K98 isolate
were transfected by electroporation with the constructs (pTrexO-
iTS, pTrexO-aTS, or empty pTrexO) and selected by G418.
Parasites were then differentiated to the metacyclic stage that was
used to infect Vero cell cultures. Trypomastigotes fromVero cells
were later cloned, thus obtaining parasites expressing iTS or aTS
recombinant proteins or none of them (named T-iTS, T-aTS, and
T-O parasite clones, respectively).
Expression of TSs proteins were analyzed by means of the
mAb 13G9 (anti-TS), which is directed to the catalytic site
and recognize both TS isoforms (Buschiazzo et al., 2002), and
with an anti-FLAG antibody to identify recombinant TSs. As
expected, flow cytometry analysis showed that all trypomastigote
groups were labeled by the mAb 13G9 but only T-iTS and T-aTS
parasites were reactive with anti-FLAG antibody (Figure 1B).
Interestingly, the total amount of TSs, endogenous plus
recombinant, was higher in the aTS than in iTS or T-O parasites,
which were similar between them (Figure 1B lower panel). The
increased total content of TSs (Figure 1B lower panel) and
the lower reactivity to iTS (Figure 1B upper panel) correlated
with the increased aTS expression found by Western blots of
trypomastigote lysates, where the expected ∼200 kDa protein
is recognized by the anti-FLAG antibodies (Figure 1C). The
appropriate localization of recombinant proteins was analyzed
by confocal microscopy. Whereas, T-O parasites were reactive
only with the mAb 13G9, T-iTS, and T-aTS parasites were
reactive for both antibodies (mAb 13G9 and anti-FLAG) and
displayed similar fluorescence patterns, as expected (Figure 1D).
The fluorescence intensity profile of anti-FLAG and mAb 13G9
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antibodies shows the overlap of both signals along the parasite
surface (Figure 1D). A colocalization analysis using the Fiji
software (Plug-in: Intensity Correlation Analysis, ICA) was
carried out, where the Pearson (R) coefficients were R =
0.8964; SEM ± 0.063 and 0.9683 ± 0.063 to T-iTS and T-aTS,
respectively. Therefore, the endogenous and recombinant TSs
were localized together following the described spotted pattern
along the trypomastigote surface (Lantos et al., 2016).
To test the TS enzymatic activity, culture-derived
trypomastigotes were pelleted, washed and allowed to shed.
T-O and T-iTS parasites displayed similar TS activity both in
pellets and supernatants while, in contrast, higher TS activity
(p < 0.05) was found for T-aTS parasites in both fractions
(Figure 1E). Therefore, increased aTS expression was observed
in T-aTS parasites either by antibodies reactivity or enzymatic
activity. All results obtained indicate the correct expression
and location of the recombinant enzymes in transfected
trypomastigotes without altering the endogenous TS.
Trypomastigotes Expressing iTS Show
Higher Invasion Ability
T. cruzi has the ability to infect a wide variety of different
mammalian cell types. To fully analyze the infection ability of
transfected parasites expressing the iTS isoform, non-phagocytic
and phagocytic cells were tested. As non-phagocytic cells,
epithelial Vero cells, primary rat fibroblasts, and cardiocytes were
used, whereas macrophages were tested as phagocytic cells.
Vero cells were infected with T-iTS, T-aTS, and T-O parasites.
The number of infected cells and intracellular amastigotes was
determined after 18 h of infection. Notably, T-iTS showed higher
values of infection (p < 0.05) and number of amastigotes/cell
(p < 0.001) as compared with control T-O and T-aTS
(Figures 2A,B). When the parasite-cell interaction lapse was
reduced to 1 h (maintaining 1:1moi), the number of infected cells
decreased (p < 0.05) although remaining higher than controls,
further supporting that these parasites were more infective
(Figure 2A). The number of amastigotes/cell was also higher
in cells infected by T-iTS than in control groups for all the
conditions assayed (Figures 2B,C). Therefore, the increment in
the observed infection capacity was independent of the parasite-
host cell interaction time.
Primary rat fibroblast cultures were infected as above. At both
times of interaction with the different parasites, the infection
values were also higher for T-iTS than those obtained with
T-aTS (Figure 2A). Moreover, the T-iTS infection rate at 18 h was
higher than for T-O parasites p< 0.05 (Figure 2A). Strikingly, the
intracellular parasite number was also superior in those cultures
infected with T-iTS respect to both control groups at 1 and 18 h
(Figures 2B,C).
Cardiocytes infection is of particular relevance in the
context of further pathology, since inflammation and subsequent
fibrosis, induced by parasitic persistence, are responsible for the
development of chagasic heart disease (Machado et al., 2013).
Cardiocytes obtained from neonatal rats were infected with the
different parasite clones. At both interaction times, levels of T-iTS
infection were significantly higher (p< 0.05) than those observed
for T-O, or T-aTS parasites. The number of amastigotes was also
higher (p < 0.001) in cells infected with T-iTS, relative to T-
aTS and T-O group (Figures 2B,C). It is important to note the
striking difference observed between the number of amastigotes
present in T-iTS infected cardiocytes relative to Vero or primary
fibroblast cell cultures at 18 h (Figures 2C,D).
In order to analyze the behavior of T-iTS parasites in
phagocytes, murine peritoneal macrophages were used. Infection
rates produced by T-iTS parasites were similar to T-aTS and
T-O trypomastigotes (Figure 2E). However, the number of
amastigotes/cell was again superior in those cells infected by
T-iTS than in T-O or T-aTS-infected cultures, p < 0.001
(Figure 2F).
iTS Pre-Incubation Did Not Modified Invasion of
Trypomastigotes Expressing iTS
In order to analyze the in vitro biological effect of iTS on cell
invasion, Vero cells were pre-treated with recombinant iTS (riTS)
before infection. Two different protocols were followed. First a
pre-treatment of cells with 5, 15, or 50µg/ml of purified riTS
during 30min was made. After washings, cells were infected
with the different parasite clones (T-O, T-iTS, T-aTS) during
1 h. Another assay consisting of treatment with 50µg/ml of
purified riTS during 30min followed by the infection during 1 h,
without washing the remnant recombinant protein was followed.
As shown in Figure 3A, previous incubation of Vero cells with
riTS (5µg/ml), induced significant increment of invasion by
T-O and T-aTS trypomastigotes, while the invasion values by
T-iTS parasites were not modified. Similar results were obtained
when 15 or 50µg/ml were used (data not shown). Simultaneous
incubation of riTS, Vero cells and parasites did not modify these
results (Figure 3B).
Inactive trans-Sialidase Expression in
Natural iTS-null Parasites Increase Its
Virulence in the Murine Model
Taken into consideration the encouraging results obtained
in the in vitro infections, we decided to test the T-iTS
trypomastigotes pathogenic abilities in the murine host. Male
BALB/cJ mice were infected with T-iTS and T-O parasites,
parasitaemia, and mortality were recorded during 60 dpi.
Mice from both groups showed circulating trypomastigotes
but parasitaemia values remained below the minimum level of
the quantification method used (10,000 parasites/ml). However,
T-iTS-infected mice began to die earlier than control group
(25 dpi vs. 35 dpi). Survival rates were 50% (6/12) vs.
72.7% (8/11) for T-iTS and T-O infected mice, respectively
(Figure 4A). Skeletal and cardiac muscle samples taken at 60
dpi from surviving mice from both groups were processed
for histopathological analysis. Cardiac samples from T-iTS
group showed higher inflammation rates than the T-O group
(p < 0.05; Figure 4B). Necrotic myocardial fibers and higher
inflammatory infiltration were observed in T-iTS samples
(Figure 4C). Skeletal muscle inflammation degree was also
higher in T-iTS infected mice than in T-O ones (p < 0.05;
Figure 4B). Whereas, T-O mice samples presented multifocal
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FIGURE 2 | Analysis of iTS role in the infection of non-phagocytic and phagocytic cells. Different assays were carried out with T-O, T-iTS, and T-aTS parasites.
(A) Infection rate of non-phagocytes cells. Infections (1 and 18 h) were carried out at 1:1 moi. T-iTS parasites were significantly more invasive. For Vero and cardiocytes
cells T-iTS parasites infection rates were higher than controls at both measured times (p < 0.05). For fibroblast cells the same differences were observed at 18 h of
infection (p < 0.05). Fibroblasts infection with T-iTS parasites was also superior to T-aTS at 1 h (p < 0.05). (B) and (C) Analysis of the number of amastigotes per cell
developed at different interaction times in non-phagocytes cells, T-iTS parasites showed higher number of amastigotes at 1 and 18 h (p < 0.001). (D) Infection of
primary cardiocyte cells. Representative fields of intracellular amastigotes number induced are shown. (E) Infection rates in murine macrophages. Similar infection
levels were observed at 18 h of interaction. (F) Number of amastigotes in murine macrophages. T-iTS showed more amastigotes per cell than controls (p < 0.01).
Results are expressed as mean ± SEM of the replicate values of three independent cultures. *p < 0.05, **p < 0.01, and ***p < 0.001.
and/or interstitial inflammatory cells infiltration, T-iTS had
inflammatory lesions that consisted of necrotic muscle fibers
with polymorphonuclears and macrophages infiltration and
necrotic parasites (Figure 4D). Interestingly, inflammation rate
was accompanied by the presence of amastigote nests in muscle
fibers in the T-iTS-infected group (4/6 positive findings) whereas
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FIGURE 3 | Infection rate of Vero cells in presence of recombinant iTS. Vero
cells were treated with riTS before (A) or during (B) the infection. (A) Cells were
incubated with 5µg/ml of riTS during 30min, then washed and infected with
T-O, T-aTS, or T-iTS parasites. (B) Cells were preincubated with 50µg/ml riTS
and then infected without washing riTS. Both treatments increased the
infection rate in T-O as well as in T-aTS assays (p < 0.05) but no difference
was observed for T-iTS parasites. Results are expressed as mean ± SEM of
the replicate values of three independent cultures. *p < 0.05.
no nests were observed in samples from the control group (0/6
positive findings) (p< 0.05; Figure 4D).
Taking together, results obtained from our approach using
transgenic parasites allowed us to demonstrate that the iTS
isoform is indeed involved in pathogenesis and therefore should
be considered as a virulence factor of T. cruzi.
DISCUSSION
To better understand the pathogenic mechanisms involved in
T. cruzi–host interaction, several virulence factors were studied.
The TS, only expressed in trypanosomatides, has been extensively
analyzed showing its relevance in invasion process and in the
manipulation of host immune system (Oliveira et al., 2014;
Freire-de-Lima et al., 2015). Previous in vitro results using
recombinant iTS support that this isoform could play a different
or complementary pathogenic role to that of the enzymatically
active protein (Todeschini et al., 2004; Ruiz Díaz et al., 2015).
iTS is encoded by conserved genes, that are only present in
DTU TcII, TcV, and TcVI, which include highly virulent strains
(Burgos et al., 2013). However, direct evidence involving iTS in
in vivo pathogenesis and invasion was lacking. Here we faced this
challenge by transfecting iTS-null parasites with a recombinant
gene that allowed us to follow its expression and association with
pathological events.
The correct expression and localization at the parasite surface
of the recombinant TSs were confirmed by several approaches.
All parasites assayed reacted with the mAb 13G9 but only TSs-
transfected parasites were recognized by the anti-FLAG labeling.
Confocal microscopy studies let us observe that the recombinant
and the endogenous TSs colocalized and, moreover, they jointly
rendered the surface dotted pattern along the trypomastigote
surface as previously described (Lantos et al., 2016). These results
clearly support that the expression of recombinant TSs does
not disturb the normal distribution of the endogenous TS on
the parasite surface. Moreover, T-aTS parasites showed more
reactivity to anti-FLAG antibodies by cytometry and Western
blot assays. In addition, T-aTS parasites produced and shed
higher TS activity than T-iTS and T-O parasites. These results
indicate that expression of the aTS recombinant protein generate
parasites with increased TS activity and preserve their ability to
shed these proteins to the milieu. In agreement, the enzymatic
activity in T-iTS and T-O parasites did not vary, indicating that
the transfection process did not interfere with the endogenous TS
expression.
A variety of mammalian cells, either phagocytic or
non-phagocytic, are invaded by T. cruzi following different
mechanisms. The infection process involves events of
attachment/detachment along the extracellular matrix until
the adhesion and recognition of target cells generate the
intracellular signaling involved in the invasion process (De Souza
et al., 2010). aTS and iTS have been proposed to participate in
these events. aTS through the sialic acid mobilization on host
cells and the generation of a sialylated epitope (Schenkman et al.,
1991). The iTS seems to be involved through the conserved
lectin-like binding properties (Cremona et al., 1999; Todeschini
et al., 2004) that might allow the attachment to glycosidic
countereceptors (Dias et al., 2008). Here we show that the
invasive ability of aTS-transfected parasites was not affected
by the increased total TS enzymatic activity induced by the
expression of the recombinant aTS. This is in agreement with
findings reported by Rubin-de-Celis et al. (2006), who observed
that TS activity overexpression does not modify the attachment
or invasion parameters. In striking contrast, iTS-transfected
parasites increased their invasive ability. The low expression,
observed by different techniques, was however enough for
the acquired invasion capacity observed not only for Vero
cells or primary fibroblast cultures but also for cardiocytes, a
parasite preferential target cell. On the other hand, when murine
macrophages were infected, no differences were observed among
the transfected parasites. A result that might be ascribed to the
known T. cruzi different invasion processes involved between
phagocytic and non-phagocytic cells (De Souza et al., 2010;
Caradonna and Burleigh, 2011).
The riTS incubation assays using different concentrations
showed the invasion rates increment of T-O and T-aTS but
not of T-iTS parasites, either with the pre-treatment or the
simultaneous incubation with parasites and Vero cells. These
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FIGURE 4 | iTS expression increases Trypanosoma cruzi virulence in mice. In vivo study of transfected parasites virulence. (A) Survival rate of T-O and T-iTS infected
mice observed during 60 days of infection. (B) Inflammation index among heart and skeletal muscle obtained from T-O and T-iTS infected mice. Higher inflammation
scores were observed for T-iTS infected mice in both tissue samples (p < 0.05). Results are expressed as mean ± SEM of inflammation index among 6 T-iTS and 6
T-O infected mice *p < 0.05. Microphotographs representative of heart (C) and skeletal muscle (D) histopathological analysis for normal, T-O and T-iTS infected mice.
For T-iTS samples notice the presence of necrotic myocardio fibers and inflammatory infiltration (black head arrow), the necrotic fibers and muscle cells remainder
(gray head arrow), and a nest of amastigote cells (white head arrow).
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are interesting finding since they are showing, in contrast to
iTS lacking parasites, that even low iTS expression is enough to
enhance their virulence capacity. Here we also show that 5µg/ml
riTS, induces T. cruzi (T-O and T-iTS) invasion increment, in
agreement with results reported by Dias et al. (2008) using a
pretreatment with 15µg/ml riTS. Our competition assays results
did not differ from that obtained with recombinant protein pre-
incubation, suggesting that the interaction of the trypomastigote-
expressed iTS with the target cells is mainly relevant in an early
step of all the invasion process. An internal signaling pathway
might be triggered in the host cell that induce a “permissive state”
to the invasion followed, in a second step, by the participation
of different surface molecules of the parasite. In any case,
our strategy using low virulent iTS-null parasites expressing
transfected iTS, unequivocally showed the significant increment
of invasion of non-phagocytic cells.
Another notable finding with T-iTS parasites was the
increased number of amastigotes found in Vero cells, cardiocytes,
fibroblasts, and macrophages. This observation was independent
of the parasite/cell interaction time allowed (1 or 18 h). It is
interesting to note that the number of amastigotes observed
in cardiocytes at 18 h of interaction was even higher to that
displayed in the other cell types. A plausible explanation for this
increment may be provided by the known T. cruzi cardiotropism.
A more efficient invasion, during the longer time of host cell-
parasite contact, may leads to multiple cellular infection that,
together with a favored intracellular development, rendered the
numerous amastigotes observed. Since the trans-sialidase is not
expressed in amastigotes and the construction was designed to
be expressed only in trypomastigotes, the increased number of
amastigotes found does not allows an easy, unique interpretation.
Among the several steps in the establishment of an intracellular
infection that can be associated with this finding, the generation
of parasitophorous vacuoles (PV) containing trypomastigotes
and their escape to the cytoplasma is a crucial step (Barrias
et al., 2013). The disruption of the PV is associated with the
desialylation of the vacuolar membrane due to the sialidase
activity of TS (Hall et al., 1992) that, in combination with TcTOX,
is the mechanism proposed for T. cruzi to access the cytoplasma
(Andrews et al., 1990). In support, (Rubin-de-Celis et al., 2006)
reported, using Y strain included in Tc II, that trypomastigotes
overexpressing TS activity access the cytoplasm faster than
control parasites. However, from our findings, it seems that the
sole increment of aTS, in trypomastigotes iTS-null, is not enough
to improve the amastigote number. Therefore, a role for iTS
in this process can be postulated, an issue that requires further
research. It can be speculated that the observed increment in the
amastigote number may be related to higher TS efficiency due to
the optimization of the binding of the trypomastigote to the PV
membrane mediated by the iTS lectin-like activity.
The most challenging assays for the analysis of iTS as a
virulence factor were those developed in vivo by mice infection.
Mortality of the T-iTS parasite-infected mice began at 25 dpi,
that is earlier than T-O infected mice, and reached 50 and 28%,
respectively. Even when low parasitaemia levels were observed,
histopathological analysis revealed interesting findings. Ventricle
and auricle from T-iTS-infected mice hearts showed different
and higher degree of inflammation respect those from T-O-
infected mice. The relevance of this organ as a preferential
T. cruzi target is known. Our in vitro results showed that T-
iTS induces higher infection rates and intracellular amastigotes
development. In mice, amastigote nests were not found but the
parasite ability to induce alterations in heart tissue was clearly
observed (Figure 4C). The development of megacardiopathy,
as the main human alteration, is a consequence of parasite
persistence inducing inflammation followed by fibrosis, which
alter the normal tissue architecture, disturbing organ functioning
(Tarleton, 2001). Histological evaluation of skeletal muscle from
T-iTS-infected mice also showed increased inflammation index
than those infected with T-O parasites. Inflammation values
were also superior than that observed in cardiac tissue and was
accompanied by the visualization of amastigotes nests in 4/6
T-iTS-infected mice.
As a whole, our results support that the trypomastigote
expression of iTS generates more aggressive parasites that not
only display increased cell invasion and intracellular amastigotes
number, but also the ability to recruit immunological cells, which
are in turn involved in increased T. cruzi-induced pathogenesis.
Therefore, iTS should be considered as another virulence factor
from T. cruzi whose acquisition during evolution associates with
an increment of its pathogenic capacities.
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